Doxycycline: Difference between revisions

From IDWiki
No edit summary
mNo edit summary
 
(One intermediate revision by the same user not shown)
Line 7: Line 7:
=== Distribution ===
=== Distribution ===


* Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this<ref>Tomasz Jodlowski, Charles R Ashby, Sarath G Nath, Doxycycline for ESBL-E Cystitis, ''Clinical Infectious Diseases'', Volume 73, Issue 1, 1 July 2021, Pages e274–e275, https://doi.org/10.1093/cid/ciaa1898</ref>
* Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this[[CiteRef::jodlowski2020do]]


== Dosing ==
== Dosing ==
Line 16: Line 16:
=== Adverse Effects ===
=== Adverse Effects ===
* Counsel on high risk of sun sensitivity and pill esophagitis
* Counsel on high risk of sun sensitivity and pill esophagitis

=== Pregnancy ===
* Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
* Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
** However, can often tolerate short courses up to 5 days without issue
** However, can often tolerate short courses up to 5 days without issue

Latest revision as of 17:38, 19 September 2024

Background

  • Tetracycline antibiotic

Spectrum of Activity

Distribution

  • Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this1

Dosing

  • Usual dosing 100 mg po BID

Safety

Adverse Effects

  • Counsel on high risk of sun sensitivity and pill esophagitis

Pregnancy

  • Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
    • However, can often tolerate short courses up to 5 days without issue

References

  1. ^  Tomasz Jodlowski, Charles R Ashby, Sarath G Nath. Doxycycline for ESBL-E Cystitis. Clinical Infectious Diseases. 2020. doi:10.1093/cid/ciaa1898.